The potential value of iron oxide nanoparticles in brain tumor treatment.
Gutin
Philip H
PH
D001932:Brain Neoplasms / Q000175:diagnosis* / Q000628:therapy; D003287:Contrast Media; D003911:Dextrans; D052203:Ferrosoferric Oxide; D019786:Gadolinium DTPA; D015316:Genetic Therapy; D006801:Humans; D007231:Infant, Newborn; D007501:Iron; D008279:Magnetic Resonance Imaging; D058185:Magnetite Nanoparticles; D010087:Oxides
D003287:Contrast Media; D003911:Dextrans; D058185:Magnetite Nanoparticles; D010087:Oxides; C097921:ferumoxtran-10; C064925:gadodiamide; D007501:Iron; C065507:ferumoxides; D019786:Gadolinium DTPA; D052203:Ferrosoferric Oxide